Restore your dog's youthful mobility with Zydax
Zydax is an injectable medication that helps recapture the youthful mobility of dogs with osteoarthritis. In a global clinical study of Zydax, pet parents evaluated 3 main activities that were affected by osteoarthritis. Zydax was shown to improve dogs’ mobility in just 28 days.
What makes Zydax unique?
- Zydax, a true Disease Modifying Osteoarthritis Drug (DMOAD), targets two key signs of OA: cartilage degeneration and inflammation
- Only Zydax has been studied in multiple clinical trials that demonstrate a rapid and lasting ability to reduce the signs of OA
- Zydax has been shown to protect cartilage health
How is Zydax given?
Zydax is easy administered by your veterinarian in a course of weekly injections given over 4 weeks. The initial course of injections typically provides 3 to 6 months of relief from the signs of osteoarthritis. After this time, a second course of Zydax may be recommended by your veterinarian.
Is Zydax safe?
Pet parents can be confident in the safety of Zydax. Over 1 million doses of Zydax have been sold with a very low incidence of side effects.
- Zydax has been studied in 30 clinical trial sites around the world, involving over 1,000 dogs of more than 65 different breeds
- Zydax can be used safely after surgery, upon discharge
- Only Zydax has been shown to be safe for long term use including concomitantly with NSAIDs
Zydax acts in multiple ways:
- Stimulates cartilage producing cells to produce healthy cartilage
- Slows cartilage damage by destructive enzymes
- Stimulates joint capsule cells to produce lubricating joint fluid
- Reduces swelling and blocks inflammatory processes
- Improves blood flow and nutrition to joint structures